Gene Patenting - Is the Pendulum Swinging Back?
New England Journal of Medicine, April 2010
Posted: 15 Apr 2010
Date Written: April 1, 2010
Abstract
This article describes the litigation over Myriad Genetics' patents on DNA sequences and genetic tests related to detection of breast cancer, which culminated in March 2010 with a federal district court decision that the companies' claims covered unpatentable subject matter. Possible implications of this unexpected ruling for biotechnology research and development are reviewed.
Keywords: gene, genetic, patent, breast cancer
Suggested Citation: Suggested Citation
Michelle M. Mello (Contact Author)
Stanford Law School ( email )
559 Nathan Abbott Way
Stanford, CA 94305-8610
United States
650-725-3894 (Phone)
HOME PAGE: http://https://law.stanford.edu/directory/michelle-m-mello/